Vukusic S, De Seze J, Edan G, et al. Effect of MD1003 (High-Dose Biotin) for the treatment of progressive MS: 36-month follow-up data. ECTRIMS 2017, P786.
International Congress of Parkinson’s Disease and Movement Disorders
jan 2020 | Bewegingsstoornissen